drugset / Trial / NCT00156962
Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to look at subject incidence of adverse events.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | — | — |